Calyx Therapeutics, Inc.

Calyx Therapeutics, Inc. is a pharmaceutical company. The company focuses on drug development for diabetes and rheumatoid arthritis. Calyx specializes in oral treatments for diabetes and inflammatory diseases, utilizing natural plant extracts with proven clinical activity in humans as the source for its discovery efforts. Pappas Ventures collaborated with the company, expanding our expertise in oral therapeutics. In 2003, Theracos acquired the company's assets.